Abstract
Purpose of Review
This review aims to outline the important echocardiographic findings observed in patients with human immunodeficiency virus (HIV) infection in the current era of treatment.
Recent Findings
HIV infection has a wide spectrum of cardiac manifestations. Myocardial and pericardial involvement were the primary cardiac manifestations in HIV patients early during the epidemic in the developed countries. In the current era of effective antiretroviral therapy, the spectrum has shifted to metabolic abnormalities (hyperlipidemia, hypertension, etc.), accelerated atherosclerotic disease, and cardiac sequelae related to these abnormalities.
Summary
Dramatic improvement in life expectancy of patients with HIV infection has resulted in a shift in the developed nations in the spectrum of cardiac manifestations, currently dominated by diastolic dysfunction and coronary artery disease. Echocardiography and advanced echocardiographic techniques play a major role in diagnosis and screening of HIV patients with underlying cardiovascular abnormalities.
Similar content being viewed by others
Abbreviations
- HIV:
-
Human Immunodeficiency virus
- AIDS:
-
Acquired immunodeficiency syndrome
- cART:
-
Combination antiretroviral therapy
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
• https://www.cdc.gov/hiv/pdf/library/reports/surveillance/cdc-hiv-surveillance-report-2018-vol-30.pdf. Most recent epidemiological statistics for HIV infection in the USA.
Autran B, Gorin I, Leibowitch M, Laroche L, Escande JP, Hewitt J, et al. Aids in a Haitian woman with cardiac Kaposi’s sarcoma and Whipple’s disease. Lancet. 1983;321(8327):767–8.
Himelman RB, Chung WS, Chernoff DN, Schiller NB, Hollander H. Cardiac manifestations of human immunodeficiency virus infection: a two-dimensional echocardiographic study. J Am Coll Cardiol. 1989;13(5):1030–6.
Blanc P, Boussuges A, Souk-aloun J, Gaüzere BA, Sainty JM. Echocardiography on HIV patients admitted to the ICU. Intensive Care Med. 1997;23(12):1279–81.
Menanga AP, Ngomseu CK, Jingi AM, Mfangam BM, Noubiap JJN, Gweth MN, et al. Patterns of cardiovascular disease in a group of HIV-infected adults in Yaoundé, Cameroon. Cardiovasc Diagn Ther. 2015;5(6):420–7.
•• Reinsch N, Kahlert P, Esser S, Sundermeyer A, Neuhaus K, Brockmeyer N, et al. Echocardiographic findings and abnormalities in HIV-infected patients: results from a large, prospective, multicenter HIV-heart study. Am J Cardiovasc Dis. 2011;1(2):176–84 Large, prospective era with insights into prevalence of echocardiographic abnormalities in HIV patients in cART era.
Erqou S, Lodebo BT, Masri A, Altibi AM, Echouffo-Tcheugui JB, Dzudie A, et al. Cardiac dysfunction among people living with HIV. JACC: Heart Failure. 2019;7(2):98–108.
D’Ascenzo F, Cerrato E, Calcagno A, Grossomarra W, Ballocca F, Omedè P, et al. High prevalence at computed coronary tomography of non-calcified plaques in asymptomatic HIV patients treated with HAART: a meta-analysis. Atherosclerosis. 2015;240(1):197–204.
Lange DC, Glidden D, Secemsky EA, Ordovas K, Deeks SG, Martin JN, et al. Mitral annular and coronary artery calcification are associated with mortality in HIV-infected individuals. Apetrei C, editor. PLoS ONE. 2015;10(7):e0130592.
•• Lind A, Reinsch N, Neuhaus K, Esser S, Brockmeyer N, Potthoff A, et al. Pericardial effusion of HIV-infected patients—results of a prospective multicenter cohort study in the era of antiretroviral therapy. Eur J Med Res. 2011;16(11):480 Large, prospective study with evidence of decreased prevalence of pericardial effusion in HIV patients in current cART era.
Harmon WG, Dadlani GH, Fisher SD, Lipshultz SE. Myocardial and pericardial disease in HIV. Curr Treat Options Cardio Med. 2002;4(6):497–509.
Katz AS, Sadaniantz A. Echocardiography in HIV cardiac disease. Prog Cardiovasc Dis. 2003;45(4):285–92.
Lipshultz SE, Fisher SD, Lai WW, Miller TL. Cardiovascular risk factors, monitoring, and therapy for HIV-infected patients. AIDS. 2003;17:S96–122.
d’Amati G, di Gioia CR, Gallo P. Pathological findings of HIV-associated cardiovascular disease. Ann N Y Acad Sci. 2001;946:23–45.
Bijl M, Dieleman JP, Simoons M, van der Ende ME. Low prevalence of cardiac abnormalities in an HIV-seropositive population on antiretroviral combination therapy. JAIDS J Acquir Immune Defic Syndr. 2001;27(3):318–20.
Holloway CJ, Ntusi N, Suttie J, Mahmod M, Wainwright E, Clutton G, et al. Comprehensive cardiac magnetic resonance imaging and spectroscopy reveal a high burden of myocardial disease in HIV patients. Circulation. 2013;128(8):814–22.
•• Wever Pinzon O, Silva Enciso J, Romero J, Makani H, Fefer J, Gandhi V, et al. Risk stratification and prognosis of human immunodeficiency virus-infected patients with known or suspected coronary artery disease referred for stress echocardiography. Circ Cardiovasc Imaging. 2011;4(4):363–70 One of the few studies outlining the role of stress echocardiography.
Butler J, Greene SJ, Shah SH, Shah SJ, Anstrom KJ, Kim RJ, et al. Diastolic dysfunction in patients with human immunodeficiency virus receiving antiretroviral therapy: results from the CHART study. J Cardiac Fail. 2019.
Luetkens JA, Doerner J, Schwarze-Zander C, Wasmuth J-C, Boesecke C, Sprinkart AM, et al. Cardiac magnetic resonance reveals signs of subclinical myocardial inflammation in asymptomatic HIV-infected patients. Circ Cardiovasc Imaging. 2016;9(3):e004091.
Hsue PY, Hunt PW, Ho JE, Farah HH, Schnell A, Hoh R, et al. Impact of HIV infection on diastolic function and left ventricular mass. Circ Heart Fail. 2010 Jan;3(1):132–9.
Rodrigues RC, de Azevedo KML, Moscavitch SD, Setubal S, Mesquita CT. The use of two-dimensional strain measured by speckle tracking in the identification of incipient ventricular dysfunction in HIV-infected patients on antiretroviral therapy, untreated HIV patients and healthy controls. Arq Bras Cardiol. 2019 [cited 2020 Apr 19]; Available from: https://doi.org/10.5935/abc.20190169.
• Capotosto L, D’Ettorre G, Ajassa C, Cavallari N, Ciardi MR, Placanica G, et al. Assessment of biventricular function by three-dimensional speckle tracking echocardiography in adolescents and young adults with human immunodeficiency virus infection: a pilot study. Cardiology. 2019;144(3–4):101–11 Recent study assessing role of strain imaging to identify subclinical cardiac involvement in asymptomatic patients.
• Alenezi F, Bloomfield GS, Okeke NL, Velagapudi P, Abudaqa L, Ijioma N, et al. Global longitudinal strain and immune status in patients living with human immunodeficiency virus. Am J Cardiol. 2019;124(6):966–71 Recent study assessing role of strain imaging.
•• Brittain EL, Duncan MS, Chang J, Patterson OV, DuVall SL, Brandt CA, et al. Increased echocardiographic pulmonary pressure in HIV-infected and -uninfected individuals in the Veterans Aging Cohort Study. Am J Respir Crit Care Med. 2018;197(7):923–32 Recent study comparing incidence of pulmonary hypertension in HIV infected and uninfected individuals.
Mette SA, Palevsky HI, Pietra GG, Williams TM, Bruder E, Prestipino AJ, et al. Primary pulmonary hypertension in association with human immunodeficiency virus infection. A possible viral etiology for some forms of hypertensive pulmonary arteriopathy. Am Rev Respir Dis. 1992 May;145(5):1196–200.
•• Çetin Güvenç R, Ceran N, Güvenç TS, Tokgöz HC, Velibey Y. Right ventricular hypertrophy and dilation in patients with human immunodeficiency virus in the absence of clinical or echocardiographic pulmonary hypertension. J Card Fail. 2018;24(9):583–93 Study demonstrating presence of right heart disease in absence of pulmonary hypertension.
Sitbon O, Lascoux-Combe C, Delfraissy J-F, Yeni PG, Raffi F, De Zuttere D, et al. Prevalence of HIV-related pulmonary arterial hypertension in the current antiretroviral therapy era. Am J Respir Crit Care Med. 2008;177(1):108–13.
•• Cerik IB, Meric M, Gulel O, Ozturk Cerik H, Coksevim M, Soylu K, et al. Echocardiographic assessment of pulmonary arterial stiffness in human immunodeficiency virus-infected patients. Echocardiography. 2019;36(6):1123–31 Role of pulmonary artery stiffness in detecting early signs of pulmonary hypertension in HIV patients.
Estok L, Wallach F. Cardiac tamponade in a patient with AIDS: a review of pericardial disease in patients with HIV infection. Mt Sinai J Med. 1998;65(1):33–9.
Heidenreich PA, Eisenberg MJ, Kee LL, Somelofski CA, Hollander H, Schiller NB, et al. Pericardial effusion in AIDS. Incidence and survival. Circulation. 1995;92(11):3229–34.
Currie PF, Sutherland GR, Jacob AJ, Bell JE, Brettle RP, Boon NA. A review of endocarditis in acquired immunodeficiency syndrome and human immunodeficiency virus infection. Eur Heart J. 1995;16(Suppl B):15–8.
Reinsch N, Esser S, Gelbrich G, Brockmeyer N, Potthoff A, Schadendorf D, et al. Valvular manifestations of human immunodeficiency virus infection—results from the prospective, multicenter HIV-HEART study. J Cardiovasc Med. 2013;14(10):733–9.
Gong G, Lin T, Yang K. Primary cardiac lymphoma mimicking atrial myxoma in an HIV and EBV-positive patient: a case report. Int J Clin Exp Pathol. 2018;11(11):5497–501.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
E.A. and K.S. declare that they have no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article is part of the Topical Collection on Echocardiography
Rights and permissions
About this article
Cite this article
Sud, K., Argulian, E. Echocardiography in Patients with HIV Infection. Curr Cardiol Rep 22, 100 (2020). https://doi.org/10.1007/s11886-020-01347-5
Published:
DOI: https://doi.org/10.1007/s11886-020-01347-5